Herbal extract / Natural product

17 marketed 11 in Phase 3

This page covers all Herbal extract / Natural product drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Na+/K+-ATPase; multiple apoptotic pathways, HMG-CoA reductase, PPAR-α, PPAR-γ, LDL receptor, NF-κB, multiple targets (non-selective).

Targets

Na+/K+-ATPase; multiple apoptotic pathways · HMG-CoA reductase, PPAR-α, PPAR-γ, LDL receptor · NF-κB, multiple targets (non-selective) · Pattern recognition receptors (Dectin-1, TLR); macrophage and NK cell activation · NF-κB, multiple antioxidant pathways · Phospholipase A2, melittin, multiple immune cell receptors · Glucocorticoid receptor; phospholipase A2

Marketed (17)

Phase 3 pipeline (11)

Patent intelligence